We recently established 5-FU-resistant (FR) cell lines by treating esophageal cancer cells with increasing concentration of 5-FU for over one year [11], and here we observed significantly increased expression of phosphorylated-AKT (p-AKT), the activated form of AKT, in the FR cells. The gene discussed is AKT1; the disease is esophageal cancer.